PhRMA: Drug Pipeline for Rare Diseases is Not Running Dry

WASHINGTON  Instead of running dry, the drug pipeline for rare diseases may be flowing with hope. As of last month, more than 450 drugs were in clinical trials for rare diseases or awaiting FDA approval.